Join today and be a part of the fastest growing B2B Network Join Now

I want to supply our medicine to different countries in Africa

  • Origin: Russia
  • Min Order: 0

Supplier Info.

  • Company Name Nguetobaye Massengar Rongar Company
  • Membership:Free
  • Business Type: Manufacturer, Trading Company, Buying Office, Agent, Distributor/Wholesaler, Government ministry/Bureau/Commission, Association, Business Service (Transportation, finance, travel, Ads, etc), Other
  • Employees Total
  • Annual Revenue

I extend my warmest greetings to each of you as the Head of African Affairs at rmasyntez. I am immensely proud to represent our company, one of Russia's largest rmaceutical firms, distinguished by its annual turnover exceeding $1 billion and a dedicated workforce of over 5,000 employees. As a company, we place great importance on producing rmaceutical products with significant social impact. Our production capacity is impressive, with an annual output of 1 billion sterile dosage forms and 30 billion non-sterile dosage forms. This vast capacity is a testament to our expertise and robust manufacturing infrastructure. Our portfolio of medications spans various therapeutic areas. Among them, we offer treatments for HIV/AIDS, non-steroidal anti-inflammatory drugs, endocrine medications (including antidiabetics, hormonal treatments, fertility drugs, etc.), cardiovascular medications, COVID-19 treatments, oncology drugs, antipsychotics, antibiotics, antivirals, anti-tuberculosis medications, anesthetics, and radiological agents, as well as drugs for rare diseases. Regarding our geogracal presence, we are established in five different cities across Russia: Saint Petersburg, Tyumen, Bratsk, Ussuriysk, and Irkutsk. This distribution enables us to meet the needs of our clients nationwide and ensures efficient delivery of our products. In our continuous quest for innovation, I am pleased to inform you about two recently developed promising products. Firstly, Saterex, a groundbreaking medication for the treatment of type 2 diabetes, offering new therapeutic options for patients. Secondly, we have developed Perchlozone, a drug aimed at treating pulmonary tuberculosis. These innovations highlight our commitment to constantly improving our products to meet urgent medical needs. We thank you for your ongoing trust in rmasyntez. Our primary objective is to provide high-quality, safe, and effective rmaceutical products to enhance the health and well-being of our patients. We are also committed to maintaining exnt relationships with our clients by offering responsive customer service and addressing all your questions and concerns. Please feel free to us if you have any specific requests, questions, or if you wish to learn more about our products. We are here to assist and support you. Sincerely, N'guetobaye Massengar Rongar Head of African Affairs

Premium Services
Need Suppliers
Girl Right
Cross Popup
Arrow 2

I Am :

Signup today to claim your Discount. Get Started before it's too late!

Arrow 1
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Ok